FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma.
作者： Hyun Woo Chung , Kye Young Lee , Hee Joung Kim , Wan Seop Kim , Young So
DOI: 10.1007/S00432-013-1545-7
关键词: Nuclear medicine 、 Adenocarcinoma 、 Hematology 、 Lung 、 Survival analysis 、 Standardized uptake value 、 Retrospective cohort study 、 Oncology 、 Stage (cooking) 、 Medicine 、 Internal medicine 、 Gene mutation
摘要: Purpose We investigated fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT)-assessed metabolic tumor volume (MTV) and total lesion …
springer.com
sci-hub.se 参考文章(38)
Narinder S. Paul, Sebastian Ley, Ur Metser, Optimal Imaging Protocols for Lung Cancer Staging Radiologic Clinics of North America. ,vol. 50, pp. 935- 949 ,(2012) , 10.1016/J.RCL.2012.06.007
Paul M. Putora, Martin Früh, Joachim Müller, FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma. Respirology. ,vol. 18, pp. 734- 735 ,(2013) , 10.1111/RESP.12083
Hisao Tonami, Katsuyuki Miura, Kengo Ito, Tsutomu Sakuma, Kotaro Higashi, Itaru Yamamoto, Takahiro Higuchi, Ichiro Matsunari, Tsutomu Ishikawa, Gencho Kuga, Yoshinori Hiramatsu, 18F-FDG Uptake by Primary Tumor as a Predictor of Intratumoral Lymphatic Vessel Invasion and Lymph Node Involvement in Non-Small Cell Lung Cancer: Analysis of a Multicenter Study The Journal of Nuclear Medicine. ,vol. 46, pp. 267- 273 ,(2005)
S Jagannath, W S Velasquez, S L Tucker, L M Fuller, P W McLaughlin, J T Manning, L B North, F C Cabanillas, Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma. Journal of Clinical Oncology. ,vol. 4, pp. 859- 865 ,(1986) , 10.1200/JCO.1986.4.6.859
Yan-Ling Lv, Dong-Mei Yuan, Ke Wang, Xiao-Hui Miao, Qian Qian, Shu-Zhen Wei, Xi-Xu Zhu, Yong Song, Diagnostic Performance of Integrated Positron Emission Tomography/Computed Tomography for Mediastinal Lymph Node Staging in Non-small Cell Lung Cancer: A Bivariate Systematic Review and Meta-Analysis Journal of Thoracic Oncology. ,vol. 6, pp. 1350- 1358 ,(2011) , 10.1097/JTO.0B013E31821D4384
Hubert Vesselle, Joseph D. Freeman, Linda Wiens, Joshua Stern, Huang Q. Nguyen, Stephen E. Hawes, Philip Bastian, Alexander Salskov, Eric Vallières, Douglas E. Wood, Fluorodeoxyglucose Uptake of Primary Non-Small Cell Lung Cancer at Positron Emission Tomography: New Contrary Data on Prognostic Role Clinical Cancer Research. ,vol. 13, pp. 3255- 3263 ,(2007) , 10.1158/1078-0432.CCR-06-1128
Meng Wang, Jing Zhao, Lian-Min Zhang, Hui Li, Jin-Pu Yu, Xiu-Bao Ren, Chang-Li Wang, Combined Erlotinib and Cetuximab overcome the acquired resistance to epidermal growth factor receptors tyrosine kinase inhibitor in non-small-cell lung cancer Journal of Cancer Research and Clinical Oncology. ,vol. 138, pp. 2069- 2077 ,(2012) , 10.1007/S00432-012-1291-2
James G. Ravenel, Evidence-based imaging in lung cancer: a systematic review. Journal of Thoracic Imaging. ,vol. 27, pp. 315- 324 ,(2012) , 10.1097/RTI.0B013E318254A198
Edward F. Patz, John Connolly, James Herndon, Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer. American Journal of Roentgenology. ,vol. 174, pp. 769- 774 ,(2000) , 10.2214/AJR.174.3.1740769
Raymond H. Mak, Subba R. Digumarthy, Alona Muzikansky, Jeffrey A. Engelman, Jo‐Anne O. Shepard, Noah C. Choi, Lecia V. Sequist, Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer. Oncologist. ,vol. 16, pp. 319- 326 ,(2011) , 10.1634/THEONCOLOGIST.2010-0300